BrightPath Biotherapeutics Co., Ltd.

TSE:4594.T

50 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014
Assets:
Current Assets:
Cash & Cash Equivalents 1,057.361,530.9692,305.0263,265.3883,018.3564,901.1776,528.7594,950.572,555.458823.737
Short Term Investments 0000000000
Cash and Short Term Investments 1,057.361,530.9692,305.0263,265.3883,018.3564,901.1776,528.7594,950.572,555.458823.737
Net Receivables 0.0060.05516.5860.2830.6590.841271.593191.853189.253171.549
Inventory 00000027.56942.3136.239148.5
Other Current Assets 123.594120.186374.438385.321309.171259.62972.20654.73610.40812.193
Total Current Assets 1,180.961,651.212,696.053,650.9923,328.1865,161.6476,900.1275,239.4692,791.3581,155.979
Non-Current Assets:
Property, Plant & Equipment, Net 0024.91848.20197.15690.76266.349115.87248.52145.255
Goodwill 0000000000
Intangible Assets 00000013.51413.78911.2552.157
Goodwill and Intangible Assets 00000013.51413.78911.2552.157
Long Term Investments 000000553926.1160
Tax Assets 000000-55-39-26.1160
Other Non-Current Assets 49.29750.23450.23450.23449.29652.05555.91239.1726.11724.074
Total Non-Current Assets 49.29750.23475.15298.435146.452142.815335.775168.83185.89371.486
Total Assets 1,230.2571,701.4442,771.2023,749.4283,474.6395,304.4637,235.9025,408.32,877.2511,227.465
Liabilities & Equity:
Current Liabilities:
Account Payables 0.020.0771.9120.4680.81428.3338.769111.73396.23103.076
Short Term Debt 112.5087.500000-16.3610
Tax Payables 12.81510.40938.81731.99834.15831.9235.04124.68910.4874.531
Deferred Revenue 12.815089.9030000016.3610
Other Current Liabilities 65.67676.4815.34155.937172.048120.483220.33849.53532.66775.834
Total Current Liabilities 191.01176.558184.655156.405172.862148.816229.107161.268128.897178.91
Non-Current Liabilities:
Long Term Debt 0000000000
Deferred Revenue Non-Current 0000000000
Deferred Tax Liabilities Non-Current 000004.8194.74.111.7152.076
Other Non-Current Liabilities 60.25857.34755.07355.38166.5454.75751.52541.77325.97622.352
Total Non-Current Liabilities 60.25857.34755.07355.38166.5459.57656.22545.88327.69124.428
Total Liabilities 251.269133.905239.728211.786239.402208.392285.332207.151156.588203.338
Equity:
Preferred Stock 0000000000
Common Stock 650.661362.1856,700.3826,459.7125,433.2115,427.8365,419.9313,774.4131,988.085642.585
Retained Earnings -2,653.715-1,485.633-10,875.815-9,391.623-7,671.989-5,814.215-3,929.896-2,352.753-1,239.092-244.627
Accumulated Other Comprehensive Income/Loss 22.84520.26822.9426.25757.21971.02957.01920.21600
Other Total Stockholders Equity 2,959.1962,670.7196,683.9676,443.2965,416.7965,411.4215,403.5163,757.9991,971.67626.169
Total Shareholders Equity 978.9871,567.5392,531.4743,537.6423,235.2375,096.0716,950.575,199.8752,720.6631,024.127
Total Equity 978.9871,567.5392,531.4743,537.6423,235.2375,096.0716,950.575,201.1492,720.6631,024.127
Total Liabilities & Shareholders Equity 1,230.2561,701.4442,771.2023,749.4283,474.6395,304.4637,235.9025,408.32,877.2511,227.465